Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT

NCT01895972 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
130
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bausch & Lomb Incorporated